Paediatric and congenital heart disease in South America: an overview

C A C Pedra1, J Haddad, S F Pedra

  • 1Catheterisation Laboratory for Congenital Heart Disease, Instituto Dante Pazzanese de Cardiologia, Av Dr Dante Pazzanese 500, 14 andar, CEP 04012-180, São Paulo, SP, Brazil. cacpedra@uol.com.br

Insights

Congenital heart disease (CHD) affects 8 in 1000 newborns, posing a significant public health challenge in South America due to high birth rates. This review examines CHD prevalence, treatment availability, and outcomes across the region.

Area of Science:

  • Cardiology
  • Public Health
  • Pediatrics

Background:

  • Congenital heart disease (CHD) represents a major global health issue, being the most common type of birth defect.
  • South American countries, characterized by high birth rates, face a substantial burden from CHD.
  • Understanding the regional epidemiology and clinical management of CHD is crucial for improving patient outcomes.

Purpose of the Study:

  • To provide a comprehensive overview of the congenital heart disease burden in South America.
  • To analyze the prevalence, treatment facilities, and outcomes of common CHDs in the region.
  • To highlight the public health implications of CHD in South America.

Main Methods:

  • Literature review of studies on congenital heart disease in South America.
  • Analysis of data on CHD prevalence, incidence, and mortality.
  • Examination of treatment modalities including medical, surgical, and catheter interventions.
  • Assessment of patient outcomes following various interventions.

Main Results:

  • Congenital heart disease affects approximately 8 per 1000 live births in South America.
  • Significant variations in prevalence and access to specialized treatment facilities exist across South American nations.
  • Outcomes following medical, surgical, and catheter interventions for common CHDs show regional disparities.

Conclusions:

  • Congenital heart disease is a significant and prevalent public health concern in South America.
  • Addressing the disparities in treatment access and quality is essential for improving outcomes for children with CHD in the region.
  • Further research and collaborative efforts are needed to mitigate the impact of CHD in South America.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...